Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.
Translate Bio has already started the production of several mRNA constructs. The company will leverage its mRNA platform for the discovery, design and manufacture of SARS-CoV-2 vaccine candidates.
Go deeper with GlobalData
Sanofi will contribute via its vaccine expertise and external research networks support. The aim is to progress vaccine candidates for further development.
